Skip to main content

Table 2 Gender based dimorphism of PPARγ2 gene polymorphism on clinical features of the study population

From: PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome

  PPARγ2 Pro12Ala
  Men Women
  PP (129) XA (8) p PP (205) XA (22) p
Age (years) 57 ± 14 57 ± 14 0.970 55 ± 13 51 ± 8 0.141
BMI (kg/m2) 29.98 ± 4.75 31.20 ± 6.69 0.492 30.98 ± 6.19 34.02 ± 6.16 0.029
WAIST (cm) 102.40 ± 12.76 104.19 ± 15.04 0.705 95.92 ± 14.05 98.61 ± 13.38 0.392
Fat Mass (kg) 27.35 ± 10.62 29.16 ± 13.56 0.646 31.88 ± 12.47 38.08 ± 12.42 0.028
Glucose (mmol/L) 7.1 ± 2.8 5.9 ± 2.1 0.278 6.1 ± 2.4 5.9 ± 2.4 0.737
Insulin (μUI/L)* 7.7 (5.2-12.0) 7.2 (4.0-14.4) 0.778 7.9 (5.1-12.6) 10.08 (8.6-15-7) 0.210
HOMA Insulin Resistance* 2.4 (1.5-3.5) 1.9 (0.9-3.6) 0.466 2.0 (1.3-3.3) 2.4 (2.1-3.6) 0.416
Systolic Blood Pressure (mmHg) 136.93 ± 15.09 134.17 ± 6.65 0.657 132.38 ± 18.51 124.77 ± 18.67 0.070
Diastolic Blood Pressure (mmHg) 82.57 ± 8.23 84.17 ± 7.36 0.642 82.33 ± 8.69 80.91 ± 11.41 0.485
Total Cholesterol (mmol/L) 5.5 ± 1.5 5.5 ± 1.0 0.939 5.7 ± 1.3 6.1 ± 1.1 0.206
Triglyceride (mmol/L)* 1.76 (1.12-2.5) 1.3(1.05-1.9) 0.414 1.37 (0.96-1.79) 1.32 (0.96-1.93) 0.687
HDL cholesterol (mmol/L) 1.2 ± 0.3 1.4 ± 0.3 0.155 1.4 ± 0.3 1.4 ± 0.4 0.463
LDL Cholesterol (mmol/L) 3.4 ± 1.4 3.4 ± 0.9 0.918 3.6 ± 1.2 4.0 ± 1.1 0.162
  1. *Median (interquartile range)